368 related articles for article (PubMed ID: 22640706)
1. Trends in gynecologic cancer care in North America.
Reade C; Elit L
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):107-29. PubMed ID: 22640706
[TBL] [Abstract][Full Text] [Related]
2. Current Quality of Gynecologic Cancer Care in North America.
Reade CJ; Elit LM
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):1-17. PubMed ID: 30683257
[TBL] [Abstract][Full Text] [Related]
3. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
4. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
9. Access to quality gynecologic oncology care: A work in progress.
Duska LR
Cancer; 2018 Jul; 124(13):2680-2683. PubMed ID: 29767847
[No Abstract] [Full Text] [Related]
10. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
[TBL] [Abstract][Full Text] [Related]
11. The Patient Protection and Affordable Care Act: what every provider of gynecologic oncology care should know.
Duska LR; Engelhard CL
Gynecol Oncol; 2013 Jun; 129(3):606-12. PubMed ID: 23500090
[TBL] [Abstract][Full Text] [Related]
12. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
13. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
14. Dental screening and referral of young children by pediatric primary care providers.
dela Cruz GG; Rozier RG; Slade G
Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
[TBL] [Abstract][Full Text] [Related]
15. Trends in cervical cancer mortality in the Americas.
Robles SC; White F; Peruga A
Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
[TBL] [Abstract][Full Text] [Related]
16. Optimum screening interventions for gynecologic malignancies.
Lea JS; Miller DS
Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
[TBL] [Abstract][Full Text] [Related]
17. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
Insinga RP; Ye X; Singhal PK; Carides GW
Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
[TBL] [Abstract][Full Text] [Related]
20. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative.
Cohn DE; Leitao M; Levenback C; Berkowitz R; Roman L; Lucci J; Kim S; Lancaster J; Odunsi K; Wakabayashi M; Goff BA
Gynecol Oncol; 2013 Sep; 130(3):403-6. PubMed ID: 23718934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
